Bausch Health Companies (BHC) had the lowest return in 2016 by a mid-cap US stock, returning -85.2%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Bausch Health Companies (BHC) | 2016 | -85.19% |
Tandem Diabetes Care (TNDM) | 2016 | -81.55% |
Civitas Resources (CIVI) | 2016 | -80.65% |
Arrowhead Pharmaceuticals (ARWR) | 2016 | -74.04% |
Enphase Energy (ENPH) | 2016 | -70.55% |
Amneal Pharmaceuticals, Inc Class A Common Stock (AMRX) | 2016 | -68.4% |
Immunitybio (IBRX) | 2016 | -66.15% |
PTC Therapeutics (PTCT) | 2016 | -65.47% |
Novocure (NVCR) | 2016 | -64.32% |
Viking Therapeutics (VKTX) | 2016 | -64.26% |
RH (RH) | 2016 | -60.53% |
TG Therapeutics (TGTX) | 2016 | -60.46% |
Catalyst Pharmaceuticals (CPRX) | 2016 | -56.97% |
Soleno Therapeutics (SLNO) | 2016 | -56.62% |
Magnite (MGNI) | 2016 | -54.08% |
Sunrun (RUN) | 2016 | -52.88% |
Abercrombie & Fitch (ANF) | 2016 | -52.86% |
Tidewater (TDW) | 2016 | -51.01% |
Acadia Healthcare (ACHC) | 2016 | -47.87% |
Amicus Therapeutics (FOLD) | 2016 | -47.13% |
OneMain (OMF) | 2016 | -46.33% |
Frontline (FRO) | 2016 | -44.87% |
TripAdvisor (TRIP) | 2016 | -44.56% |
Atlanta Braves Holdings, Inc Series A Common Stock (BATRA) | 2016 | -43.08% |
Halozyme Therapeutics (HALO) | 2016 | -41.64% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
